Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 6200-6299

6200. Q. Rahman, M. Lohani, E. Dopp, H. Pemsel, L. Jonas, D.G. Weiss, D. Schiffmann, “Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts,” Environ. Health Perspect. 110(August 2002):797-800.

6201. T. Uchino, H. Tokunaga, M. Ando, H. Utsumi, “Quantitative determination of OH radical generation and its cytotoxicity induced by TiO2-UVA treatment,” Toxicol. in Vitro 16(October 2002):629-635.

6202. J.K. Kim, W.K. Lee, E.J. Lee, Y.J. Cho, K.H. Lee, H.S. Kim, Y. Chung, K.A. Kim, Y. Lim, “Mechanism of silica- and titanium dioxide-induced cytotoxicity in alveolar macrophages,” J. Toxicol. Environ. Health A 58(10 December 1999):437-450.

6203. F. Afaq, P. Abidi, R. Matin, Q. Rahman, “Cytotoxicity, pro-oxidant effects and antioxidant depletion in rat lung alveolar macrophages exposed to ultrafine titanium dioxide,” J. Appl. Toxicol. 18(September-October 1998):307-312.

6204. A. Takaga, K. Sai, T. Umemura, R. Hasegawa, Y. Kurokawa, “Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats,” Cancer Lett. 57(April 1991):55-60.

6205. K. Ohmori, N. Kudo, K. Katayama, Y. Kawashima, “Comparison of the toxokinetics between perfluorocarboxylic acids with different carbon chain length,” Toxicology 184(3 March 2003):135-140.

6206. N. Kudo, Y. Kawashima, “Induction of triglyceride accumulation in the liver of rats by perfluorinated fatty acids with different carbon chain lengths: comparison with induction of peroxisomal beta-oxidation,” Biol. Pharm. Bull. 26(January 2003):47-51.

6207. J.B. Wright, K. Lam, D. Hansen, R.E. Burrell, “Efficacy of topical silver against fungal burn wound pathogens,” Am. J. Infect. Control 27(August 1999):344-350.

6208. R.G. Sibbald, A.C. Browne, P. Coutts, D. Queen, “Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care,” Ostomy Wound Manage. 47(October 2001):38-43.

6209. J.B. Wright, K. Lam, A.G. Buret, M.E. Olson, R.E. Burrell, “Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing,” Wound Repair Regen. 10(May-June 2002):141-151.

6210. Smith+Nephew, “Wound Management: Acticoat,” and; see also NUCRYST Pharmaceuticals,

6211. L. Broxmeyer, D. Sosnowska, E. Miltner, O. Chacon, D. Wagner, J. McGarvey, R.G. Barletta, L.E. Bermudez, “Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens,” J. Infect. Dis. 186(15 October 2002):1155-1160.

6212. Robert F. Service, “Nanomaterials show signs of toxicity,” Science 300(11 April 2003):243; (html), (pdf)

6213. Kurt Kleiner, “How safe is nanotech?” New Scientist (29 March 2003):14-15.

6214. Chiu-Wing Lam, John T. James, Richard McCluskey, Robert L. Hunter, “Histopathological study of single-walled carbon nanotubes in mice 7 and 90 days after instillation into the lungs,” paper 23, Nanotechnology and the Environment session, 225th ACS National Meeting, 23-27 March 2003, abstract online at; “Pulmonary toxicity study of nanotubes in mice,” NanoDays 2002, CBEN/Rice University, 14 October 2002.

6215. David B. Warheit, B.R. Laurence, K.L. Reed, T.R. Webb, “Pulmonary-toxicity-screening studies with single-wall carbon nanotubes,” paper 24, Nanotechnology and the Environment session, 225th ACS National Meeting, 23-27 March 2003, abstract online at

6216. Gunter Oberdorster, “Effects and fate of inhaled ultrafine particles,” paper 22, Nanotechnology and the Environment session, 225th ACS National Meeting, 23-27 March 2003, abstract online at; “Exposure to airborne ultrafine and nano particles: Potential health effects,” NanoDays 2002, CBEN/Rice University, 14 October 2002.

6217. HPV Robust Summaries and Test Plan, CAS# 86508-42-1, Perfluoro compounds, C5-C18, including CAS#3 1 1-89-7 Perfluorotributyl amine, December 2001;

6218. S. Nonaka, H. Shiratori, Y. Saijoh, H. Hamada, “Determination of left-right patterning of the mouse embryo by artificial nodal flow,” Nature 418(4 July 2002):96-99, 29-30 (comment).

6219. W. Westbroek, J. Lambert, J.M. Naeyaert, “The dilute locus and Griscelli syndrome: gateways towards a better understanding of melanosome transport,” Pigment Cell Res. 14(October 2001):320-327.

6220. K.B. Avraham, “The genetics of deafness: a model for genomic and biological complexity,” Ernst Schering Res. Found. Workshop 36(2002):271-297.

6221. J.G. Seidman, C. Seidman, “The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms,” Cell 104(23 February 2001):557-567.

6222. Manfred Schliwa, Gunther Woehlke, “Molecular motors,” Nature 422(17 April 2003):759-765;

6223. C. Zhao, J. Takita, Y. Tanaka, M. Setou, T. Nakagawa, S. Takeda, H.W. Yang, S. Terada, T. Nakata, Y. Takei, M. Saito, S. Tsuji, Y. Hayashi, N. Hirokawa, “Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta,” Cell 105(1 June 2001):587-597; Cell 106(13 July 2001):127 (erratum).

6224. J.R. Marszalek, P. Ruiz-Lozano, E. Roberts, K.R. Chien, L.S. Goldstein, “Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II,” Proc. Natl Acad. Sci. (USA) 96(27 April 1999):5043-5048,; D.M. Supp, D.P. Witte, S.S. Potter, M. Brueckner, “Mutation of an axonemal dynein affects left-right asymmetry in inversus viscerum mice,” Nature 389(30 October 1997):963-966.

6225. H. Olbrich et al, “Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry,” Nature Genet. 30(February 2002):143-144; L. Bartoloni et al, “Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia,” Proc. Natl. Acad. Sci. (USA) 99(6 August 2002):10282-10286;

6226. R.B. Vallee, C. Tai, N.E. Faulkner, “LIS1: cellular function of a disease-causing gene,” Trends Cell Biol. 11(April 2001):155-160.

6227. H. Qin, J.L. Rosenbaum, M.M. Barr, “An autosomal recessive polycystic kidney disease gene homolog is involved in intraflagellar transport in C. elegans ciliated sensory neurons,” Curr. Biol. 11(20 March 2001):457-461.

6228. A.W. Tai, J.Z. Chuang, C. Bode, U. Wolfrum, C.H. Sung, “Rhodopsin's carboxy-terminal cytoplasmic tail acts as a membrane receptor for cytoplasmic dynein by binding to the dynein light chain Tctex-1,” Cell 97(25 June 1999):877-887.

6229. J.R. Marszalek, X. Liu, E.A. Roberts, D. Chui, J.D. Marth, D.S. Williams, L.S. Goldstein, “Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors,” Cell 102(21 July 2000):175-187; D.S. Williams, “Transport to the photoreceptor outer segment by myosin VIIa and kinesin II,” Vision Res. 42(February 2002):455-462.

6230 M. Schliwa, ed., Molecular Motors, VCH-Wiley, Weinheim, 2003.

6231. D.D. Hurd, M. Stern, W.M. Saxton, “Mutation of the axonal transport motor kinesin enhances paralytic and suppresses Shaker in Drosophila,” Genetics 142(January 1996):195-204.

6232. S. Gunawardena, L.S. Goldstein, “Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila,” Neuron 32(8 November 2001):389-401.

6233. B.H. LaMonte, K.E. Wallace, B.A. Holloway, S.S. Shelly, J. Ascano, M. Tokito, T. Van Winkle, D.S. Howland, E.L. Holzbaur, “Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration,” Neuron 34(30 May 2002):715-727.

6234. Majid Hafezparast et al, “Mutations in dynein link motor neuron degeneration to defects in retrograde transport,” Science 300(2 May 2003):808-812.

6235. Gregory L. Timp, “Silicon nano-biotechnology,” lecture presentation at Zyvex Corp., 16 May 2003.

6236. V.S. Smentkowski, J.T. Yates, Jr., “Fluoroalkyl iodide photodecomposition on diamond(100) – an efficient route to the fluorination of diamond surfaces,” 1996;; V.S. Smentkowski, J.T. Yates, Jr., Xiaojie Chen, W.A. Goddard, III, “Fluorination of diamond – C4F9I and CF3I photochemistry on diamond (100),” submitted to Surface Science;

6237. Leide L.G. Silva, E.J. Corat, K. Iha, P.T.A. Sumodjo, “Potentiodynamic behavior of the boron-doped diamond electrodes in Na2SO4 with pH 2 to 12,” Electrochemical Society symposium;

6238. T.E. Creighton, Proteins, W.H. Freeman & Co., New York, 1984.

6239. D.E. Ingber, “The architecture of life,” Sci. Amer. 278(January 1998):48-57.

6240. C.S. Chen, M. Mrksich, S. Huang, G.M. Whitesides, D.E. Ingber, “Micropatterned surfaces for control of cell shape, position, and function,” Biotechnol. Prog. 14(May-June 1998):356-363.

6241. L.E. Dike, C.S. Chen, M. Mrksich, J. Tien, G.M. Whitesides, D.E. Ingber, “Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates,” In Vitro Cell Dev. Biol. Anim. 35(September 1999):441-448.

6242. S. Huang, D.E. Ingber, “Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks,” Exp. Cell Res. 261(25 November 2000):91-103.

6243. N. Wang, E. Ostuni, G.M. Whitesides, D.E. Ingber, “Micropatterning tractional forces in living cells,” Cell Motil. Cytoskeleton 52(June 2002):97-106.

6244. K.K. Parker, A.L. Brock, C. Brangwynne, R.J. Mannix, N. Wang, E. Ostuni, N.A. Geisse, J.C. Adams, G.M. Whitesides, D.E. Ingber, “Directional control of lamellipodia extension by constraining cell shape and orienting cell tractional forces,” FASEB J. 16(August 2002):1195-1204.

6245. D.E. Ingber, “Tensegrity II. How structural networks influence cellular information processing networks,” J. Cell Sci. 116(15 April 2003):1397-1408.

6246. H.G. Craighead, C.D. James, A.M.P. Turner, “Chemical and topographical patterning for directed cell attachment,” Curr. Opin. Solid State Mater. Sci. 5(2001):177-184;

6247. Y. Wang, X. Cheng, Y. Hanein, B. Ratner, K.F. Bohringer, “Protein patterning with programmable surface chemistry chips,” Sixth Intl. Conf. on Miniaturized Chemical and Biochemical Analysis Systems (Micro TAS), Nara, Japan, 2002.

6248. Candace Stuart, “New nanomaterial studies warn, ‘Handle with care’,” SmallTimes 3(May/June 2003):15. See also: Candace Stuart, “Survey finds the smaller the size, the bigger the possible risks,” SmallTimes online, 17 April 2003,

6249. F.H.C. Crick, J.D. Watson, “The complementary structure of deoxyribonucleic acid,” Proc. R. Soc. London Ser. A. Mathematical and Physical Sciences 223(1954):80-96.

6250. M. Schneider, T. Hartung, “Induction of the chemokines IL-8 and MCP-1 in human whole blood by a cell-lysate of human fibroblast cells,” Immunol. Lett. 75(1 January 2001):163-165.

6251. J.E. Dunphy, “The fibroblast: a ubiquitous ally for the surgeon,” N. Engl. J. Med. 268(1963):1367.

6252. R. Bucala, L.A. Spiegel, J. Chesney, M. Hogan, A. Cerami, “Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair,” Mol. Med. 1(November 1994):71-81; J. Chesney, R. Bucala, “Peripheral blood fibrocytes: novel fibroblast-like cells that present antigen and mediate tissue repair,” Biochem. Soc. Trans. 25(May 1997):520-524; J. Chesney, R. Bucala, “Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis,” Curr. Rheumatol. Rep. 2(December 2000):501-505; Riichiro Abe, Seamas C. Donnelly, Tina Peng, Richard Bucala, Christine N. Metz, “Peripheral blood fibrocytes: differentiation pathway and migration to wound sites,” J. Immunol. 166(15 June 2001):7556-7562;

6253. S.J. Oh, H. Kurz, B. Christ, J. Wilting, “Platelet-derived growth factor-B induces transformation of fibrocytes into spindle-shaped myofibroblasts in vivo,” Histochem. Cell Biol. 109(April 1998):349-357.

6254. H. Castro-Malaspina, W. Ebell, S. Wang, “Human bone marrow fibroblast colony-forming units (CFU-F),” Prog. Clin. Biol. Res. 154(1984):209-236; K.H. Wlodarski, A. Janowska-Wieczorek, “Precursor cells of fibroblast colony forming unit in the normal and pathologic human bone marrow and in the peripheral blood,” Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 111(1984):686-691; E.A. Luriia, A.Ia. Fridenshtein, A.G. Grosheva, A. Gleiberman, “Colony-forming fibroblast precursors of the circulating blood,” Biull. Eksp. Biol. Med. 108(December 1989):712-714 (in Russian); G. Prindull, Z. Ben-Ishay, W. Ebell, M. Bergholz, T. Dirk, B. Prindull, “CFU-F circulating in cord blood,” Blut. 54(June 1987):351-359.

6255. X. Cheng, A.T. Kan, M.B. Tomson, “Adsorption/desorption characteristics of naphthalene onto/from C60 surface,” presentation at the 5th Intl. Conf. on Integrated Nano/Micro/Biotechnology for Space and Medical and Commercial Applications, NanoSpace 2002 Future Technology Frontiers, Galveston Island, TX, 24-28 June 2002.

6256. X. Cheng, A.T. Kan, M.B. Tomson, “Adsorption/desorption characteristics of organic compounds onto/from nanomaterial surfaces,” presentation at the 224th American Chemical Society Fall National Meeting, Boston, MA, 18-22 August 2002; Xukun Cheng, Amy Kan, and Mason Tomson, “Environmental impact of carbon nanomaterials,” presentation at the NanoDays 2002 Conference for the Center for Biological and Environmental Nanotechnology (CBEN), Rice University, Houston, TX, 14-15 October 2002; M.B. Tomson, “Nanomaterial transport in the environment,” presentation at the School of Continuing Studies, Rice University, Houston, TX, 23 October 2002.

6257. William H. Noon, Kevin D. Ausman, Richard E. Smalley, Jianpeng Ma, “Molecular dynamics simulation of bio-fullerene interfaces,” presentation at the NanoDays 2002 Conference for the Center for Biological and Environmental Nanotechnology (CBEN), Rice University, Houston, TX, 14-15 October 2002.

6258. Y. Gao, A.T. Kan, R. Wahi, V. Colvin, “Interaction of heavy metal with inorganic nanomaterials and their environmental impact,” poster presentation at the NanoDays 2002 Conference for the Center for Biological and Environmental Nanotechnology (CBEN), Rice University, Houston, TX, 14-15 October 2002.

6259. Barnaby J. Feder, “Nanotechnology Group to Address Safety Concerns,” The New York Times, 7 July 2003;


Last updated on 16 April 2004